Dr. Bouxsein is Assistant Professor of Orthopedic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA. Dr. Kaufman is a member of the Santa Clarita Orthopedic and Sports Medicine Group, Santa Clarita, CA. Dr. Tosi is Director, Bone Health Program, Division of Orthopaedic Surgery, Children's National Medical Center, Washington, DC. Dr. Cummings is Professor of Epidemiology and Biostatistics (emeritus), University of California, San Francisco, and Director, San Francisco Coordinating Center, California Pacific Medical Center Research Institute, San Francisco, CA. Dr. Lane is Chief, Metabolic Bone Disease Service, Hospital for Special Surgery, New York, NY. Dr. Johnell is Professor, Department of Orthopaedic Surgery, UMAS, Malmö, Sweden.
Reprint requests: Dr. Bouxsein, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215.
None of the following authors or the departments with which they are affiliated has received anything of value from or owns stock in a commercial company or institution related directly or indirectly to the subject of this article: Dr. Bouxsein, Dr. Lane, and Dr. Johnell. Dr. Kaufman or the department with which he is affiliated has received nonincome support (such as equipment or services), commercially derived honoraria, or other non-research-related funding (such as paid travel) from Merck, Aventis, and Proctor & Gamble. Dr. Tosi or the department with which she is affiliated serves as a consultant to or is an employee of Merck. Dr. Cummings or the department with which he is affiliated has received research or institutional support from Eli Lilly, Pfizer, Amgen, and Organon. Dr. Cummings or the department with which he is affiliated has received nonincome support (such as equipment or services), commercially derived honoraria, or other non-research-related funding (such as paid travel) from Eli Lilly and Merck. Travel expenses associated with the development of these guidelines were provided by Aventis Pharmaceuticals, Merck & Co, Inc, and Procter & Gamble Pharmaceuticals, Inc. None of the authors received honoraria for the development of these guidelines. The opinions expressed represent the consensus of the authors.
